MassChallenge Healthcare Challenge Program
Supports healthcare and life science startups to strengthen partnerships and scaling through a MassChallenge industry track.
MassChallenge is a Boston-based, globally operating nonprofit accelerator founded in 2009. Its Healthcare Challenge Program is one of several industry-specific challenge tracks that match mid-to-late-stage startups with corporate partners seeking validated solutions. The 2026 cycle ran January through May 2026 across a four-month program structure; applications closed November 5, 2025. Corporate cโฆ
Healthcare and life sciences startups with validated products/solutions ready for corporate scaling partnerships.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides โGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Pitch Deck Example: Slides, Storyline, and Video Script
See a grant pitch deck example with slide outline, EIC-style pitch logic, demo-video script, and grant-vs-investor deck differences.
Find grantsStartup Grant Application Process: From Search to Submission
Step-by-step startup grant application process covering grant search, eligibility screening, documents, budgets, portals, review timelines, and submission.
More from MassChallenge
All grants from this funder โMassChallenge Israel (Seed)
๐ฎ๐ฑMassChallenge ยท United States
Supports Israeli startups with no-equity acceleration, corporate engagement, and international venture exposure through MassChallenge Israel.
MassChallenge Healthcare & Life Sciences Traction Program
๐บ๐ธMassChallenge ยท United States
Runs MassChallenge Healthcare and Life Sciences Traction for early-stage founders with equity-free validation, mentoring, and investor readiness.
MassChallenge Security & Resiliency Traction Program
๐บ๐ธMassChallenge ยท United States
Runs MassChallenge Security and Resiliency Traction for early cyber, infrastructure, and defense-adjacent founders with scale preparation.
MassChallenge Switzerland
๐จ๐ญMassChallenge ยท United States
Supports Swiss agtech, industrial, and health startups through a MassChallenge program with mentorship, networking, and investment pathways.
MassChallenge FinTech Challenge Program
๐บ๐ธMassChallenge ยท United States
Supports fintech startups with proven products through MassChallenge's program for modern financial services, payments, and regtech pilots.
Security & Resiliency Traction Program
MassChallenge ยท United States
Runs a 10-week, no-cost, non-dilutive accelerator for early-stage security, resiliency, and dual-use founders, from Pre-Seed through Series A+, culminating in enterprise pilots and investor-ready pitches.
Similar grants
Browse the directory โNOURISH: Autoimmunity Digital Health Challenge
๐บ๐ธOADR-ORWH ยท United States
Awards up to $650,000 across three phases for digital tools tracking autoimmune nutrition.
MIT Solve Global Challenges
๐บ๐ธMIT ยท United States
Supports teams tackling global challenges by selecting and backing scalable ideas through MIT Solve challenge pathways.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
๐บ๐ธNIH ยท United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
๐บ๐ธNCATS ยท United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge
๐บ๐ธNIH ยท United States
Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.
Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge โ Track 1
๐บ๐ธNCI ยท United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.